Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Ann Oncol ; 30(2): 243-249, 2019 02 01.
Article in English | MEDLINE | ID: mdl-30462160

ABSTRACT

BACKGROUND: Colorectal cancer (CRC) has been shown to acquire RAS and EGFR ectodomain mutations as mechanisms of resistance to epidermal growth factor receptor (EGFR) inhibition (anti-EGFR). After anti-EGFR withdrawal, RAS and EGFR mutant clones lack a growth advantage relative to other clones and decay; however, the kinetics of decay remain unclear. We sought to determine the kinetics of acquired RAS/EGFR mutations after discontinuation of anti-EGFR therapy. PATIENTS AND METHODS: We present the post-progression circulating tumor DNA (ctDNA) profiles of 135 patients with RAS/BRAF wild-type metastatic CRC treated with anti-EGFR who acquired RAS and/or EGFR mutations during therapy. Our validation cohort consisted of an external dataset of 73 patients with a ctDNA profile suggestive of prior anti-EGFR exposure and serial sampling. A separate retrospective cohort of 80 patients was used to evaluate overall response rate and progression free survival during re-challenge therapies. RESULTS: Our analysis showed that RAS and EGFR relative mutant allele frequency decays exponentially (r2=0.93 for RAS; r2=0.94 for EGFR) with a cumulative half-life of 4.4 months. We validated our findings using an external dataset of 73 patients with a ctDNA profile suggestive of prior anti-EGFR exposure and serial sampling, confirming exponential decay with an estimated half-life of 4.3 months. A separate retrospective cohort of 80 patients showed that patients had a higher overall response rate during re-challenge therapies after increasing time intervals, as predicted by our model. CONCLUSION: These results provide scientific support for anti-EGFR re-challenge and guide the optimal timing of re-challenge initiation.


Subject(s)
Colorectal Neoplasms/drug therapy , Drug Resistance, Neoplasm , Neoplastic Cells, Circulating/pathology , Protein Kinase Inhibitors/therapeutic use , Colorectal Neoplasms/genetics , Colorectal Neoplasms/pathology , Disease Progression , ErbB Receptors/antagonists & inhibitors , ErbB Receptors/genetics , Follow-Up Studies , Humans , Mutation , Neoplasm Metastasis , Prognosis , Retrospective Studies , Survival Rate , ras Proteins/genetics
2.
J Virol ; 75(18): 8864-7, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11507233

ABSTRACT

Jaagsiekte sheep retrovirus (JSRV) replicates in the lungs of sheep and causes the secretion of copious lung fluid containing the virus. Adaptation of JSRV to infection and replication in the lung and its apparent resistance to the denaturing activity of lung fluid suggest that vectors based on JSRV would be useful for gene therapy targeted to the lung. We show here that a retrovirus vector bearing the JSRV Env is stable during treatment with lung surfactant while an otherwise identical vector bearing an amphotropic Env is inactivated. Furthermore, the JSRV vector was stable during centrifugation, allowing facile vector concentration, and showed no loss of activity after six freeze-thaw cycles. However, the JSRV vector was inactivated by standard disinfectants, indicating that JSRV vectors pose no unusual safety risk related to their improved stability under other conditions.


Subject(s)
Biological Products , Gene Products, env/metabolism , Genetic Vectors , Jaagsiekte sheep retrovirus/growth & development , Pulmonary Surfactants/pharmacology , Animals , Centrifugation , Freezing , Gene Products, env/genetics , Gene Products, gag/genetics , Gene Products, gag/metabolism , Gene Products, pol/genetics , Gene Products, pol/metabolism , Genetic Vectors/drug effects , Humans , Jaagsiekte sheep retrovirus/drug effects , Mice , Moloney murine leukemia virus , Sheep , Tumor Cells, Cultured , Virus Activation
3.
Opt Lett ; 16(22): 1780-2, 1991 Nov 15.
Article in English | MEDLINE | ID: mdl-19784138

ABSTRACT

What is to our knowledge the first high-density (>10(12) bits/cm(3)) optical recording of digital information in a multilayered, three-dimensional format is reported. Information is written as submicrometer volume elements of increased refractive index in a photopolymer by two-photon excitation of a photoinitiator at the waist of a highly focused beam from a colliding-pulse mode-locked laser. Quadratic dependence of two-photon excitation on intensity confines polymerization to the focal volume. Information is read with sufficient axial resolution by differential interference contrast microscopy. This write-once, read-many technique should increase the capacity of the spinning disk format by 100-fold.

4.
Science ; 248(4951): 73-6, 1990 Apr 06.
Article in English | MEDLINE | ID: mdl-2321027

ABSTRACT

Molecular excitation by the simultaneous absorption of two photons provides intrinsic three-dimensional resolution in laser scanning fluorescence microscopy. The excitation of fluorophores having single-photon absorption in the ultraviolet with a stream of strongly focused subpicosecond pulses of red laser light has made possible fluorescence images of living cells and other microscopic objects. The fluorescence emission increased quadratically with the excitation intensity so that fluorescence and photo-bleaching were confined to the vicinity of the focal plane as expected for cooperative two-photon excitation. This technique also provides unprecedented capabilities for three-dimensional, spatially resolved photochemistry, particularly photolytic release of caged effector molecules.


Subject(s)
Lasers , Microscopy, Fluorescence/methods , Radiation , Animals , Cell Line , Chromosomes/ultrastructure , Fluorescent Dyes , Kidney/ultrastructure , Photochemistry , Swine , Ultraviolet Rays
5.
Minn Med ; 51(3): 331, 1968 Mar.
Article in English | MEDLINE | ID: mdl-5649327
SELECTION OF CITATIONS
SEARCH DETAIL
...